Kingdom of Saudi Arabia (The) Publication of Final Terms (9336N)

TIDM93GS

RNS Number : 9336N

Kingdom of Saudi Arabia (The)

03 February 2021

THE KINGDOM OF SAUDI ARABIA

acting through the

MINISTRY OF FINANCE

Publication of Pricing Supplements

The following pricing supplements (the Pricing Supplements) are available for viewing:

1. Pricing Supplement in relation to the issue of U.S.$2,750,000,000 2.250% Notes due 2033 by the Kingdom of Saudi Arabia, acting through the Ministry of Finance (the Issuer) under the Issuer's Global Medium Term Note Programme (the Programme); and

2. Pricing Supplement in relation to the issue of U.S.$2,250,000,000 3.450% Notes due 2061 by the Issuer under the Programme

The Offering Circular dated 26 January 2021 (the Offering Circular) in relation to the Programme is also available for viewing.

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/9336N_1-2021-2-3.pdf

http://www.rns-pdf.londonstockexchange.com/rns/9336N_2-2021-2-3.pdf

http://www.rns-pdf.londonstockexchange.com/rns/9336N_3-2021-2-3.pdf

For further information, please contact:

Ministry of Finance of the Kingdom of Saudi Arabia

King Abdulaziz Road

Riyadh 11177

Kingdom of Saudi Arabia

   Telephone:      + 966 11 405 0000 
   Attention:        National Debt Management Centre 

DISCLAIMER - INTENDED ADDRESSEES

The Pricing Supplements referred to above must be read in conjunction with the Offering Circular.

Please note that the information contained in the Pricing Supplements and the Offering Circular may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Pricing Supplements and/or the Offering Circular) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Pricing Supplements and/or the Offering Circular is not addressed. Prior to relying on the information contained in the Pricing Supplements and/or the Offering Circular you must ascertain from the Pricing Supplements and the Offering Circular whether or not you are part of the intended addressees of the information contained therein.

In particular, the Pricing Supplements and/or the Offering Circular do not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction. The securities referred to in the Pricing Supplements and/or the Offering Circular have not been and will not be registered under the United States Securities Act of 1933, as amended (the Securities Act) and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act, and the rules and regulations thereunder. The Issuer does not intend to register any of the securities referred to in the Pricing Supplements and/or the Offering Circular in the United States or to conduct a public offering of the securities referred to in the Pricing Supplements and/or the Offering Circular in the United States or elsewhere.

The Pricing Supplements and/or the Offering Circular has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the Issuer, its advisers nor any person who controls any of them nor any director, officer, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Pricing Supplements and/or the Offering Circular made available to you in electronic format and the hard copy version available to you on request from the Issuer.

Your right to access this service is conditional upon complying with the above requirements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PFTFLFIAFVIVIIL

(END) Dow Jones Newswires

February 04, 2021 02:00 ET (07:00 GMT)